Anti RBM3 mAb (Clone CL0296, ATL-AMAb90655 w/enhanced validation)

Atlas Antibodies

Catalog No.: ATL-AMAb90655-25

Protein Description: RNA binding motif (RNP1, RRM) protein 3
Gene Name: RBM3
Alternative Gene Name: IS1-RNPL
Clone ID: CL0296
Isotype: IgG1
Interspecies mouse/rat: ENSMUSG00000031167: 94%, ENSRNOG00000005387: 96%
Entrez Gene ID: 5935
Uniprot ID: P98179
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Product Specifications

• Application: WB, ICC, IHC
• Reactivity: Human
• Clonality: Monoclonal IgG1 (Clone No.: CL0296)
• Host: Mouse
• Gene ID - Mouse: ENSMUSG00000031167
• Gene ID - Rat: ENSRNOG00000005387
• Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.

Citations for Anti RBM3 mAb (Clone CL0296, ATL-AMAb90655 w/enhanced validation) – 15 Found

Florianova, Livia; Xu, Bin; Traboulsi, Samer; Elmansi, Hazem; Tanguay, Simon; Aprikian, Armen; Kassouf, Wassim; Brimo, Fadi. Evaluation of RNA-binding motif protein 3 expression in urothelial carcinoma of the bladder: an immunohistochemical study. World Journal Of Surgical Oncology. 2015;13( 26577765):317. 

Boman, Karolina; Andersson, Gustav; Wennersten, Christoffer; Nodin, Björn; Ahlgren, Göran; Jirström, Karin. Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study. Biomarker Research. 5( 28293425):10. 

Karnevi, Emelie; Dror, Liv Ben; Mardinoglu, Adil; Elebro, Jacob; Heby, Margareta; Olofsson, Sven-Erik; Nodin, Björn; Eberhard, Jakob; Gallagher, William; Uhlén, Mathias; Jirström, Karin. Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification. Oncotarget. 2018;9(5):6188-6200. 

Wahlin, Sara; Boman, Karolina; Moran, Bruce; Nodin, Björn; Gallagher, William M; Karnevi, Emelie; Jirström, Karin. Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity. Bmc Cancer. 2022;22(1):131. 

Siesing, Christina; Petersson, Alexandra; Ulfarsdottir, Thora; Chattopadhyay, Subhayan; Nodin, Björn; Eberhard, Jakob; Brändstedt, Jenny; Syk, Ingvar; Gisselsson, David; Jirström, Karin. Delineating the intra-patient heterogeneity of molecular alterations in treatment-naïve colorectal cancer with peritoneal carcinomatosis. Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc. 2022;35(7):979-988. 

Ehlén, Asa; Brennan, Donal J; Nodin, Björn; O'Connor, Darran P; Eberhard, Jakob; Alvarado-Kristensson, Maria; Jeffrey, Ian B; Manjer, Jonas; Brändstedt, Jenny; Uhlén, Mathias; Pontén, Fredrik; Jirström, Karin. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer. Journal Of Translational Medicine. 2010;8( 20727170):78. 

Jonsson, Liv; Bergman, Julia; Nodin, Björn; Manjer, Jonas; Pontén, Fredrik; Uhlén, Mathias; Jirström, Karin. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study. Journal Of Translational Medicine. 2011;9( 21777469):114. 

Ehlén, Åsa; Nodin, Björn; Rexhepaj, Elton; Brändstedt, Jenny; Uhlén, Mathias; Alvarado-Kristensson, Maria; Pontén, Fredrik; Brennan, Donal J; Jirström, Karin. RBM3-regulated genes promote DNA integrity and affect clinical outcome in epithelial ovarian cancer. Translational Oncology. 2011;4(4):212-21. 

Jonsson, Liv; Gaber, Alexander; Ulmert, David; Uhlén, Mathias; Bjartell, Anders; Jirström, Karin. High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression. Diagnostic Pathology. 2011;6( 21955582):91. 

Hjelm, Barbara; Brennan, Donal J; Zendehrokh, Nooreldin; Eberhard, Jakob; Nodin, Björn; Gaber, Alexander; Pontén, Fredrik; Johannesson, Henrik; Smaragdi, Kristina; Frantz, Christian; Hober, Sophia; Johnson, Louis B; Påhlman, Sven; Jirström, Karin; Uhlen, Mathias. High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer. Proteomics. Clinical Applications. 2011;5(11-12):624-35. 

Nodin, Björn; Fridberg, Marie; Jonsson, Liv; Bergman, Julia; Uhlén, Mathias; Jirström, Karin. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma. Diagnostic Pathology. 2012;7( 22805320):82. 

Boman, Karolina; Segersten, Ulrika; Ahlgren, Göran; Eberhard, Jakob; Uhlén, Mathias; Jirström, Karin; Malmström, Per-Uno. Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer. Bmc Urology. 2013;13( 23565664):17. 

Dubois, Louise; Andersson, Karl; Asplund, Anna; Björkelund, Hanna. Evaluating real-time immunohistochemistry on multiple tissue samples, multiple targets and multiple antibody labeling methods. Bmc Research Notes. 2013;6( 24350799):542. 

Olofsson, Sven-Erik; Nodin, Björn; Gaber, Alexander; Eberhard, Jakob; Uhlén, Mathias; Jirström, Karin; Jerkeman, Mats. Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer. Plos One. 10(3):e0121300. 

Salomonsson, Annette; Micke, Patrick; Mattsson, Johanna S M; La Fleur, Linnea; Isaksson, Johan; Jönsson, Mats; Nodin, Björn; Botling, Johan; Uhlén, Mathias; Jirström, Karin; Staaf, Johan; Planck, Maria; Brunnström, Hans. Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancer. Cancer Medicine. 2020;9(15):5609-5619.